Moat Ross sold KNSA
October 30, 2026 · Form 4 insider transaction
Moat Ross sold 37,775 shares of Kiniksa Pharmaceuticals International, plc at $92.00 per share, a transaction worth $3.48M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
37,775
Price
$92.00
Total value
$3.48M
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after48,127
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.36 to $92.35. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.